• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心内科和内科医院中心 7148 例心房颤动患者的现况和处理:ATA AF 研究。

Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study.

机构信息

Department of Cardiology, Maggiore Hospital, Bologna, Italy.

出版信息

Int J Cardiol. 2013 Sep 10;167(6):2895-903. doi: 10.1016/j.ijcard.2012.07.019. Epub 2012 Aug 11.

DOI:10.1016/j.ijcard.2012.07.019
PMID:22884698
Abstract

BACKGROUND

Atrial fibrillation (AF) is associated with a high risk of stroke and mortality.

AIMS

To describe the difference in AF management of patients (pts) referred to Cardiology (CARD) or Internal Medicine (MED) units in Italy.

METHODS AND RESULTS

From May to July 2010, 360 centers enrolled 7148 pts (54% in CARD and 46% in MED). Median age was 77 years (IQR 70-83). Hypertension was the most prevalent associated condition, followed by hypercholesterolemia (28.9%), heart failure (27.7%) and diabetes (24.3%). MED pts were older, more frequently females and more often with comorbidities than CARD pts. In the 4845 pts with nonvalvular AF, a CHADS2 score ≥ 2 was present in 53.0% of CARD vs 75.3% of MED pts (p<.0001). Oral anticoagulants (OAC) were prescribed in 64.2% of CARD vs 46.3% of MED pts (p<.0001); OAC prescription rate was 49.6% in CHADS2 0 and 56.2% in CHADS2 score ≥ 2 pts. At the adjusted analysis patients managed in MED had a significantly lower probability to be treated with OAC. Rate control strategy was pursued in 51.4% of the pts (60.5% in MED and 43.6% in CARD) while rhythm control was the choice in 39.8% of CARD vs 12.9% of MED pts (p<.0001).

CONCLUSIONS

Cardiologists and internists seem to manage pts with large epidemiological differences. Both CARD and MED specialists currently fail to prescribe OAC in accordance with stroke risk. Patients managed by MED specialists have a lower probability to receive an OAC treatment, irrespective of the severity of clinical conditions.

摘要

背景

心房颤动(AF)与中风和死亡率的风险增加有关。

目的

描述意大利心脏病学(CARD)或内科(MED)科室就诊的患者(pts)的 AF 管理差异。

方法和结果

2010 年 5 月至 7 月,360 个中心纳入了 7148 名患者(54%在 CARD,46%在 MED)。中位年龄为 77 岁(IQR 70-83)。高血压是最常见的相关疾病,其次是高胆固醇血症(28.9%)、心力衰竭(27.7%)和糖尿病(24.3%)。MED 患者年龄较大,女性较多,合并症较多。在 4845 名非瓣膜性 AF 患者中,CARD 患者的 CHADS2 评分≥2 占 53.0%,而 MED 患者的 CHADS2 评分≥2 占 75.3%(p<.0001)。CARD 患者中有 64.2%的患者开具了口服抗凝剂(OAC),而 MED 患者中有 46.3%的患者开具了 OAC(p<.0001);在 CHADS2 0 患者中,OAC 处方率为 49.6%,在 CHADS2 评分≥2 患者中,OAC 处方率为 56.2%。在调整分析中,在 MED 治疗的患者接受 OAC 治疗的可能性明显较低。51.4%的患者采用了心率控制策略(60.5%在 MED,43.6%在 CARD),而 39.8%的 CARD 患者采用了节律控制策略,而 MED 患者中只有 12.9%采用了节律控制策略(p<.0001)。

结论

心脏病专家和内科医生似乎对具有较大流行病学差异的患者进行管理。CARD 和 MED 专家目前都未能根据中风风险开具 OAC。无论临床情况的严重程度如何,由 MED 专家管理的患者接受 OAC 治疗的可能性较低。

相似文献

1
Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study.心内科和内科医院中心 7148 例心房颤动患者的现况和处理:ATA AF 研究。
Int J Cardiol. 2013 Sep 10;167(6):2895-903. doi: 10.1016/j.ijcard.2012.07.019. Epub 2012 Aug 11.
2
Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.心脏病专家和内科医生管理的心房颤动患者的抗心律失常策略:心房颤动抗栓治疗(ATA-AF)调查
J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):626-35. doi: 10.2459/JCM.0000000000000110.
3
Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study.心房颤动患者口服抗凝药物的决策:ATA-AF 研究。
Eur J Intern Med. 2013 Jun;24(4):324-32. doi: 10.1016/j.ejim.2013.04.008. Epub 2013 May 16.
4
Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.波兰单一地区医院临床实践中的房颤患者卒中预防的抗凝和抗血小板治疗。
Kardiol Pol. 2013;71(12):1260-5. doi: 10.5603/KP.a2013.0179. Epub 2013 Aug 30.
5
[Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].[心房颤动合并认知功能障碍患者口服维生素K拮抗剂的使用频率]
Pol Merkur Lekarski. 2014 May;36(215):302-6.
6
Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).欧洲心脏病专家对心房颤动患者的预后和治疗:EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase(EORP-AF Pilot 注册研究)的一年随访结果。
Eur Heart J. 2014 Dec 14;35(47):3365-76. doi: 10.1093/eurheartj/ehu374. Epub 2014 Aug 31.
7
Atrial fibrillation management, outcomes and predictors of stable disease in daily practice: prospective non-interventional study.心房颤动管理、结局和稳定疾病的预测因素:前瞻性非干预性研究。
Int J Cardiol. 2013 Aug 10;167(3):750-6. doi: 10.1016/j.ijcard.2012.03.053. Epub 2012 Apr 3.
8
Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project.利用植入式心脏复律除颤器的心房颤动诊断功能改善血栓预防:意大利多中心AF ANGELS项目
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):182-8. doi: 10.1161/CIRCOUTCOMES.111.964205. Epub 2012 Feb 28.
9
Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation.80 岁及以上非瓣膜性心房颤动患者抗血栓治疗的结局和安全性。
Am J Cardiol. 2011 May 15;107(10):1489-93. doi: 10.1016/j.amjcard.2011.01.025. Epub 2011 Mar 21.
10
Baseline characteristics and management of patients with atrial fibrillation/flutter in the emergency department: results of a prospective, multicentre registry in China.急诊科心房颤动/扑动患者的基线特征与管理:一项中国前瞻性多中心注册研究的结果
Intern Med J. 2014 Aug;44(8):742-8. doi: 10.1111/imj.12487.

引用本文的文献

1
Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillation.抗血栓治疗处方模式的时间趋势:房颤住院患者的真实世界单中心研究。
World J Cardiol. 2022 Nov 26;14(11):576-598. doi: 10.4330/wjc.v14.i11.576.
2
Anticoagulation in frail older people.老年体弱患者的抗凝治疗
J Geriatr Cardiol. 2019 Nov;16(11):844-846. doi: 10.11909/j.issn.1671-5411.2019.11.005.
3
Management of oral anticoagulation in very old patients with non valvular atrial fibrillation related acute ischemic stroke.
高龄非瓣膜性心房颤动相关急性缺血性脑卒中患者的口服抗凝药物管理。
J Thromb Thrombolysis. 2020 Jan;49(1):86-93. doi: 10.1007/s11239-019-01972-0.
4
Internists feel the rhythm.内科医生能感觉到节奏。
Intern Emerg Med. 2020 Mar;15(2):183-185. doi: 10.1007/s11739-019-02202-4. Epub 2019 Oct 9.
5
Connexins and Atrial Fibrillation in Obstructive Sleep Apnea.阻塞性睡眠呼吸暂停中的连接蛋白与心房颤动
Curr Sleep Med Rep. 2018 Dec;4(4):300-311. doi: 10.1007/s40675-018-0130-7. Epub 2018 Oct 26.
6
Research on Algorithm of Extracting PPG Signal for Detecting Atrial Fibrillation based on Probability Density Function.基于概率密度函数的用于检测心房颤动的PPG信号提取算法研究
Open Biomed Eng J. 2015 Aug 31;9:179-184. doi: 10.2174/1874120701509010179. eCollection 2015.
7
Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation.肾小球滤过率:心房颤动的一个预后标志物——抗血栓药物治疗心房颤动的亚分析
Clin Cardiol. 2018 Dec;41(12):1570-1577. doi: 10.1002/clc.23065. Epub 2018 Dec 4.
8
NOAC in "real world" patients with atrial fibrillation in Italy: results from the ISPAF-2 (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study.意大利“真实世界”房颤患者中的新型口服抗凝剂:ISPAF-2(房颤患者社会认知调查研究)调查研究结果。
Intern Emerg Med. 2018 Oct;13(7):1069-1075. doi: 10.1007/s11739-018-1896-9. Epub 2018 Jun 28.
9
Mechanisms and Drug Development in Atrial Fibrillation.心房颤动的机制与药物开发。
Pharmacol Rev. 2018 Jul;70(3):505-525. doi: 10.1124/pr.117.014183.
10
ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives.意大利心脏病学国家协会立场文件:用于心房颤动卒中预防的直接口服抗凝剂——临床情况与未来展望
Eur Heart J Suppl. 2017 May;19(Suppl D):D70-D88. doi: 10.1093/eurheartj/sux007. Epub 2017 May 2.